Scholarlink

<p>Over recent years, the use of diabetes technologies during pregnancy has increased substantially, in parallel with the rising prevalence of type 1 diabetes (T1D), type 2 diabetes (T2D) and gestational diabetes mellitus (GDM) in women of reproductive age. Achieving the very tight glycaemic targets recommended in pregnancy remains challenging because of high glucose variability, progressive insulin resistance and an increased risk of hypoglycaemia, with a relevant management burden for patients. Continuous glucose monitoring (CGM), continuous subcutaneous insulin infusion (CSII) and, more recently, automated insulin delivery (AID) systems represent effective tools to improve glycaemic control and selected maternal-foetal outcomes. This narrative review, based on the main available evidence and on the recent AMD-SID Diabetes and Pregnancy Study Group Position Statement, summarises indications, limitations and practical implications of the use of diabetes technologies during pregnancy, with a specific focus on real-world implementation and on the role of the multidisciplinary team in patient selection and management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Uso delle tecnologie nel diabete in gravidanza: stato dell’arte e implicazioni pratiche

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月5日

查看全文
  • Veronica Resi

摘要

Over recent years, the use of diabetes technologies during pregnancy has increased substantially, in parallel with the rising prevalence of type 1 diabetes (T1D), type 2 diabetes (T2D) and gestational diabetes mellitus (GDM) in women of reproductive age. Achieving the very tight glycaemic targets recommended in pregnancy remains challenging because of high glucose variability, progressive insulin resistance and an increased risk of hypoglycaemia, with a relevant management burden for patients. Continuous glucose monitoring (CGM), continuous subcutaneous insulin infusion (CSII) and, more recently, automated insulin delivery (AID) systems represent effective tools to improve glycaemic control and selected maternal-foetal outcomes. This narrative review, based on the main available evidence and on the recent AMD-SID Diabetes and Pregnancy Study Group Position Statement, summarises indications, limitations and practical implications of the use of diabetes technologies during pregnancy, with a specific focus on real-world implementation and on the role of the multidisciplinary team in patient selection and management.